EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Advancements and Perspectives in Nanotechnology and Nanomedicine

Olga Morozova iD

Viruses · 2025

DOI: 10.3390/v17050638 ↗

Kurz gefasst

Editorial in der Zeitschrift Viruses, 2025. Verfasst von Olga Morozova. Beteiligte Einrichtung: Institute of Future Biophysics, 9/7 Institutsky Per., Dolgoprudny 141700, Moscow Region, Russia. Hauptthemen laut MEDLINE: Nanomedicine, Nanotechnology. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progress in atom visualization and miniaturization in microelectronics resulted in the discovery of nanomaterials in the second half of the 20th century [...]

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanomedicineNanotechnologyHumansNanostructures

Autor:innen und Institutionen

  • Institute of Future Biophysics, 9/7 Institutsky Per., Dolgoprudny 141700, Moscow Region, Russia.
  • Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 1a Malaya Pirogovskaya Street, Moscow 119435, Russia.
  • Ivanovsky Institute of Virology of the National Research Center of Epidemiology and Microbiology of N.F. Gamaleya of the Russian Ministry of Health, 16 Gamaleya Street, Moscow 123098, Russia.

ORCID-Profile: Olga Morozova

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Morozova, O. (2025). Advancements and Perspectives in Nanotechnology and Nanomedicine. Viruses. https://doi.org/10.3390/v17050638

Vancouver

Morozova O. Advancements and Perspectives in Nanotechnology and Nanomedicine. Viruses. 2025. doi:10.3390/v17050638

BibTeX
@article{Morozova2025,
  author = {Morozova, Olga},
  title = {Advancements and Perspectives in Nanotechnology and Nanomedicine},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17050638}
}
Kostenlos starten →